Discover 2,355 paid clinical trials in Joliet, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,355
A Multicenter Multinational Observational Study of Children With Hypochondroplasia
for
Hypochondroplasia
Location: Chicago IL, Milwaukee WI, Saint Louis MO, Columbia MO,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 0 - 15
Code: NCT06212947
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
for
Carcinoma, Non-Small Cell Lung
Location: Chicago IL, Decatur IL, Bridgeton MO, Owensboro KY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06868277
Phase3, Recruiting
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Chicago IL, Milwaukee WI, Grand Rapids MI, Detroit MI,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06921785
Phase3, Recruiting
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
for
Non-small Cell Lung Cancer, Colorectal Carcinoma,
Location: Chicago IL, Milwaukee WI, St Louis MO, Nashville TN,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06218914
Phase1, Recruiting
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
for
Patients With Non-Small Cell Lung Cancer
Location: Chicago IL, Nashville TN, Smyrna TN, Franklin TN,
Sponsor: OSE Immunotherapeutics
Sex: All
Age: 18+
Code: NCT06472245
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
for
Non-small Cell Lung Cancer (NSCLC)
Location: Chicago IL, Niles IL, Zion IL, Bridgeton MO, Detroit MI,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07291037
Phase3, Recruiting
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Location: Chicago IL, Milwaukee WI, Indianapolis IN, St Louis MO,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06465810
Recruiting
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Chicago IL, Cleveland OH, Nashville TN, Omaha NE,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05061550
Phase2, Recruiting
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
for
Cancer Weight Loss
Location: Skokie IL, Detroit MI, Omaha NE, Lincoln NE, Memphis TN,
Sponsor: Endevica Bio
Sex: All
Age: 18+
Code: NCT06937177
Phase2, Recruiting
Kidney Precision Medicine Project
for
Acute Kidney Failure, Acute Kidney Insufficiency,
Location: Chicago IL, Rochester MN, Cleveland OH, Minneapolis MN,
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 18+
Code: NCT04334707
Recruiting
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: Chicago IL, Milwaukee WI, Atlanta GA, Richmond VA,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT06137118
Phase1, Phase2, Recruiting
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
for
Relapsed/Refractory Multiple Myeloma
Location: Chicago IL, Milwaukee WI, Iowa City IA, Ann Arbor MI,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05850234
Phase1, Phase2, Recruiting
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
for
Prostate Cancer
Location: Evanston IL
Sponsor: Endeavor Health
Sex: Male
Age: 40 - 69
Code: NCT05295407
Recruiting
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
for
Metastatic Castration-Resistant Prostate Cancer
Location: Chicago IL, Omaha NE, Boston MA, Tampa FL, Miami FL
Sponsor: AstraZeneca
Sex: Male
Age: 18+
Code: NCT06879041
Phase1, Recruiting
A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers
for
Diabetic Foot Ulcers
Location: Chicago IL, Southfield MI, Hamilton, Kittaning PA,
Sponsor: SANUWAVE, Inc.
Sex: All
Age: 22+
Code: NCT01824407
Phase3, Recruiting
REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman Syndrome
for
Angelman Syndrome
Location: Chicago IL, Cincinnati OH, Columbus OH, London,
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: All
Age: 2 - 50
Code: NCT06914609
Phase3, Recruiting
A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers
for
Oral Squamous Cell Carcinoma
Location: Chicago IL, Cleveland OH, Miami FL, Duarte CA
Sponsor: Privo Technologies
Sex: All
Age: 18 - 70+
Code: NCT05893888
Phase2, Phase3, Recruiting
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
for
Neurofibromatosis Type 1
Location: Chicago IL, Indianapolis IN, St Louis MO, Cincinnati OH,
Sponsor: Healx Limited
Sex: All
Age: 12+
Code: NCT06541847
Phase2, Recruiting
Stroke Thrombectomy and Aneurysm Registry
for
Stroke, Thromboses, Intracranial, Aneurysm, Brain
Location: Chicago IL, Evanston IL, Wyoming MI, Indianapolis IN,